Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 702, pseudogene (RN7SL702P) is a human genomic pseudogene derived from the 7SL RNA, a key RNA component of the signal recognition particle (SRP) complex. Pseudogenes like RN7SL702P are DNA sequences similar to known genes but are generally considered non-functional; they do not encode proteins and are thought to arise from either duplication or retrotransposition events. The large majority of 7SL RNA–like sequences in the human genome are pseudogenes, with only a handful serving as functional 7SL RNA genes. RN7SL702P may be transcribed, but there is no evidence that it functions as a receptor, enzyme, transporter, or other canonical therapeutic target[1][6][7][8]. Some pseudogenes have been observed to play a role as non-coding RNAs impacting gene regulation (e.g., by acting as miRNA sponges or decoys), but such a function is not established for this specific pseudogene[4][5].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 702, pseudogene (RN7SL702P).